Adaptive sample size calculations in group sequential trials
- PMID: 11315085
- DOI: 10.1111/j.0006-341x.1999.01286.x
Adaptive sample size calculations in group sequential trials
Abstract
A method for group sequential trials that is based on the inverse normal method for combining the results of the separate stages is proposed. Without exaggerating the Type I error rate, this method enables data-driven sample size reassessments during the course of the study. It uses the stopping boundaries of the classical group sequential tests. Furthermore, exact test procedures may be derived for a wide range of applications. The procedure is compared with the classical designs in terms of power and expected sample size.
Similar articles
-
Data-driven analysis strategies for proportion studies in adaptive group sequential test designs.J Biopharm Stat. 2003 Nov;13(4):585-603. doi: 10.1081/BIP-120024196. J Biopharm Stat. 2003. PMID: 14584710
-
Estimation of a parameter and its exact confidence interval following sequential sample size reestimation trials.Biometrics. 2004 Dec;60(4):910-8. doi: 10.1111/j.0006-341X.2004.00246.x. Biometrics. 2004. PMID: 15606411
-
On sample size and inference for two-stage adaptive designs.Biometrics. 2001 Mar;57(1):172-7. doi: 10.1111/j.0006-341x.2001.00172.x. Biometrics. 2001. PMID: 11252594
-
Sample size estimation: an overview with applications to orthodontic clinical trial designs.Am J Orthod Dentofacial Orthop. 2011 Oct;140(4):e141-6. doi: 10.1016/j.ajodo.2011.04.021. Am J Orthod Dentofacial Orthop. 2011. PMID: 21967951 Review.
-
A group sequential, response-adaptive design for randomized clinical trials.Control Clin Trials. 2003 Oct;24(5):506-22. doi: 10.1016/s0197-2456(03)00092-8. Control Clin Trials. 2003. PMID: 14500050 Review.
Cited by
-
Bayesian group sequential enrichment designs based on adaptive regression of response and survival time on baseline biomarkers.Biometrics. 2022 Mar;78(1):60-71. doi: 10.1111/biom.13421. Epub 2021 Jan 27. Biometrics. 2022. PMID: 33438761 Free PMC article.
-
Sample Size Reestimation in Stochastic Curtailment Tests With Time-to-Events Outcome in the Case of Nonproportional Hazards Utilizing Two Weibull Distributions With Unknown Shape Parameters.Pharm Stat. 2025 Jan-Feb;24(1):e2429. doi: 10.1002/pst.2429. Epub 2024 Aug 18. Pharm Stat. 2025. PMID: 39155271
-
Glycyrrhizin in patients who failed previous interferon alpha-based therapies: biochemical and histological effects after 52 weeks.J Viral Hepat. 2012 Aug;19(8):537-46. doi: 10.1111/j.1365-2893.2011.01579.x. Epub 2012 Feb 24. J Viral Hepat. 2012. PMID: 22762137 Free PMC article. Clinical Trial.
-
Flexible analytical methods for adding a treatment arm mid-study to an ongoing clinical trial.J Biopharm Stat. 2012;22(4):758-72. doi: 10.1080/10543406.2010.528103. J Biopharm Stat. 2012. PMID: 22651113 Free PMC article.
-
Prophylactic intravitreal 5-fluorouracil and heparin to prevent proliferative vitreoretinopathy in high-risk patients with retinal detachment: study protocol for a randomized controlled trial.Trials. 2018 Jul 16;19(1):384. doi: 10.1186/s13063-018-2761-x. Trials. 2018. PMID: 30012187 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical